These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4261957)

  • 21. CSF-changes of HVA and 5-HIAA during intermittent and continuous Parkinson therapy with particular regard to prodipin application.
    Oppel F; Schulze G
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Mar; 11(2):76-80. PubMed ID: 347467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia.
    Lindvall B; Olsson JE
    Adv Neurol; 1990; 53():117-22. PubMed ID: 1700581
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of cerebrospinal fluid drawn at pneumoencephalography in the study of monoamine metabolism in man.
    Garelis E; Sourkes TL
    J Neurol Neurosurg Psychiatry; 1974 Jun; 37(6):704-10. PubMed ID: 4210686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between estimated premorbid adjustment and CSF homovanillic acid and 5-hydroxyindoleacetic acid levels.
    Leckman JF; Bowers MB; Sturges JS
    Am J Psychiatry; 1981 Apr; 138(4):472-7. PubMed ID: 6163366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa.
    Lenman JA; Turnbull MJ; Reid A; Fleming AM
    J Neurol Sci; 1977 Jun; 32(2):219-25. PubMed ID: 874521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid homovanillic acid in Huntington's chorea.
    Klawans HL
    J Neurol Sci; 1971 Jul; 13(3):277-9. PubMed ID: 4256172
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of the lying and sitting positions on the gradients of 5-HIAA and HVA in lumbar cerebrospinal fluid.
    Gateless D; Stanley M; Träskman-Bendz L; Gilroy J
    Biol Psychiatry; 1984 Nov; 19(11):1585-9. PubMed ID: 6083808
    [No Abstract]   [Full Text] [Related]  

  • 28. [Homovanillic (HVA) and 5-hydroxyindoleacetic (5-HIAA) acid concentration in the cerebrospinal fluid of patients with supratentorial tumors and symptoms of intracranial hypertension (preliminary report)].
    Majchrzak H; Kmieciak-Kołada K; Herman Z; Wencel T
    Neurol Neurochir Pol; 1980; 14(1):87-90. PubMed ID: 6154903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurophysiological measures related to levels of 5-hydroxyindoleacetic acid, homovanillic acid and tryptophan in cerebrospinal fluid of psychiatric patients.
    Gottfries CG; von Knorring L; Perris C
    Neuropsychobiology; 1976; 2(1):1-8. PubMed ID: 1004696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
    Sjöström R; Ekstedt J; Anggård E
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Determination of cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid in sleep disorders, epilepsy, degenerative chorea and acute cerebral vascular diseases].
    Livrea P
    Acta Neurol (Napoli); 1976; 31(5):580-600. PubMed ID: 138342
    [No Abstract]   [Full Text] [Related]  

  • 32. Biochemical aspects of Huntington's chorea.
    Caraceni T; Calderini G; Consolazione A; Riva E; Algeri S; Girotti F; Spreafico R; Branciforti A; Dall'olio A; Morselli PL
    J Neurol Neurosurg Psychiatry; 1977 Jun; 40(6):581-7. PubMed ID: 143508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased cerebrospinal fluid dopamine and 3,4-dihydroxyphenylacetic acid levels in Huntington's disease: evidence for an overactive dopaminergic brain transmission.
    Garrett MC; Soares-da-Silva P
    J Neurochem; 1992 Jan; 58(1):101-6. PubMed ID: 1309230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
    Cramer H; Warter JM; Renaud B
    Adv Neurol; 1984; 40():431-5. PubMed ID: 6198888
    [No Abstract]   [Full Text] [Related]  

  • 35. Sites of origin in the central nervous system of monoamine metabolites measured in human cerebrospinal fluid.
    Garelis E; Sourkes TL
    J Neurol Neurosurg Psychiatry; 1973 Aug; 36(4):625-9. PubMed ID: 4731331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
    Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
    Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal fluid homovanillic acid and parkinsonism in Huntington's disease.
    Kurlan R; Goldblatt D; Zaczek R; Jeffries K; Irvine C; Coyle J; Shoulson I
    Ann Neurol; 1988 Aug; 24(2):282-4. PubMed ID: 2972251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions between central monoaminergic systems: dopamine-serotonin.
    Roccatagliata G; Albano C; Cocito L; Maffini M
    J Neurol Neurosurg Psychiatry; 1979 Dec; 42(12):1159-62. PubMed ID: 160445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cerebrospinal HVA and 5-HIAA in patients with endogenous depression in the course of treatment].
    Loeb DC; Roccatagliata G; Albano C; Abbruzzese G
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):27-32. PubMed ID: 6158092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
    Bonnet AM; Tell G; Schechter PJ; Grove J; Saint-Hilaire MH; De Smet Y; Agid Y
    Mov Disord; 1987; 2(2):117-23. PubMed ID: 2973560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.